• SENSEX
    NIFTY 50
big story

Decoding Lok Sabha election results 2019: 6 reasons how the verdict became a pro-incumbency vote

272/543
L :7
W :346
L :3
W :89
NDA :353 | Need More Seats to win
Need 183 More Seats to win | UPA : 92
LOK SABHA ELECTION RESULTS 2019
Total Constituencies
543
Voter Turnout
67.11%
NDA : 353
2014 : 354 Seats
BJP
303
+
SS
18
+
Other
32
UPA : 92
2014 : 66 Seats
INC
52
+
DMK
23
+
Other
17
OTH : 97
2014 : 107 Seats
YSRCP
22
+
TMC
22
+
Other
53
Healthcare

Why biosimilars are a huge opportunity for the Indian biopharmaceutical industry

Updated : January 02, 2019 09:29 AM IST

The global biosimilars market is estimated to touch $15 billion by 2020.
There is increased activity and growth in the biosimilars market globally with some of the best-selling biologics going off-patent.
To meet its global aspirations as a vital supplier of biosimilars, India must address some of the fundamental concerns that investors have about the Indian legal and regulatory framework for biopharmaceuticals.
Why biosimilars are a huge opportunity for the Indian biopharmaceutical industry
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV